不同植物脂肪源对吉富罗非鱼生长性能、肌肉脂肪酸和生理生化指标的影响

配制了6种等氮等脂的饲料饲喂(12.320.02) g的吉富罗非鱼8周, 探讨罗非鱼对不同脂肪源的利用效果,筛选出适合吉富罗非鱼的植物脂肪源。6种饲料中分别添加大豆油(SO)、棕榈油(PO)、棉籽油(CO)、菜籽油(RO)、磷脂(SL)和1:1:1:1:1大豆油-棕榈油-棉籽油-菜籽油-磷脂混合油(MIX)。结果显示: (1)菜籽油组特定生长率显著高于棕榈油组、棉籽油组、磷脂油组和混合油组(P0.05), 大豆油组显著高于棉籽油组和棕榈油组(P0.05)。菜籽油组饲料系数显著低于棉籽油组、磷脂油组和棕榈油组(P0.05), 与其他各组无显著性差异(P0.05); (2)肌肉脂肪酸明显受饲料脂肪源影响, 棕榈油组肌肉脂肪酸组成与饲料脂肪酸组成相关性最大(P0.05), 棉籽油组肌肉脂肪酸组成与饲料脂肪酸组成相关性最小(P0.05); (3)棕榈油组天冬氨酸转氨酶活性显著高于菜籽油组(P0.05)。棉籽油组高密度脂蛋白胆固醇含量和低密度脂蛋白胆固醇含量显著高于菜籽油组(P0.05), 大豆油组肝脏脂蛋白酯酶活性显著高于棉籽油组和菜籽油组(P0.05)。研究结果表明: 菜籽油、大豆油可以作为吉富罗非鱼饲料中良好的脂肪源, 棉籽油不利于吉富罗非鱼生长。     

饲料中添加溶菌酶对吉富罗非鱼生长、免疫-抗氧化功能及血清抗菌性能的影响

为研究在饲料中添加不同水平的溶菌酶制品对吉富罗非鱼(GIFT, Oreochromis niloticus)生长性能、免疫-抗氧化功能和血清抗菌性能的影响, 选用平均体重为(11.350.08)g的吉富罗非鱼960尾, 随机分为6组(每组4个重复, 每个重复40尾), 分别投喂基础饲料(对照组)和5种添加水平分别为18、36、54、72和90 mg/kg溶菌酶制品的试验饲料, 养殖周期为60d。结果表明: (1) 54 mg/kg溶菌酶添加组鱼的生长性能和饲料利用情况最优, 增重率和蛋白质效率均显著高于对照组, 饲料系数显著低于对照组(P0.05); 肝体比随溶菌酶添加水平的增加呈现下降趋势, 90 mg/kg添加组显著低于对照组(P0.05); 脾脏指数在36和54mg/kg添加组显著低于对照组(P0.05); 全鱼粗蛋白和粗灰分含量在54 mg/kg添加组均呈现较高水平, 显著高于对照组(P0.05)。(2)溶菌酶添加水平对罗非鱼的免疫-抗氧化能力产生影响, 54和72 mg/kg添加水平能显著提高鱼体血清和肝脏的超氧化物歧化酶、过氧化氢酶活性, 降低丙二醛含量(P0.05); 肝脏溶菌酶活性在54和72 mg/kg添加组均显著高于对照组(P0.05), 而血清溶菌酶活性随溶菌酶添加水平的增加呈现下降趋势(L90组除外), 显著低于对照组(P0.05)。(3)血清抗菌试验显示, 54和72 mg/kg溶菌酶添加组罗非鱼对大肠杆菌、金黄色葡萄球菌、嗜水气单胞菌和溶藻弧菌的抑制能力显著高于对照组(P0.05), 而对枯草芽孢杆菌的抵抗能力最低, 比对照组分别低34.71%和42.21% (P0.05)。结果表明, 在本试验条件下, 在吉富罗非鱼饲料中添加54 mg/kg溶菌酶制品可以改善其生长性能; 当添加水平为54和72 mg/kg时, 罗非鱼的免疫-抗氧化能力和血清抗菌性能均得到了显著提高。     

吉富罗非鱼IGF2基因分离及其单核苷酸多态性与体型、增重相关性

胰岛素样生长因子2(insulin-like growth factor2,IGF2)是控制动物生长和脂肪沉积的重要基因之一。本文采用PCR方法分离了吉富罗非鱼(GIFT strain Nile tilapia Oreochromis niloticus)IGF2基因5475bp,包含由4个外显子组成的整个阅读框669bp以及3个内含子。通过比对吉富罗非鱼10个个体IGF2序列,共发现11处单核苷酸多态性(single nucleotide polymorphism,SNP)位点,本文检测了内含子1的621nt(C/T)和外显子3的161nt(A/G)两位点在192尾吉富罗非鱼中的基因型分布,并分析不同基因型与体型、增重的相关性。使用四引物扩增受阻体系PCR检测内含子1的621nt基因型,结果显示,CC、CT、TT基因型频率在雄鱼中分别为0.32、0.32、0.36,在雌鱼中分别为0.38、0.38、0.24;与体型、增重的相关性分析表明,此位点不同基因型只与雄鱼体型(体高/体长)显著相关(P0.05),CC型个体显著高于CT和TT型个体。外显子3的A/G转换导致了MSPⅠ酶切位点改变,使用PCR-RFLP法检测该位点基因型,结果显示整个群体中不存在AA基因型,在雄鱼中,GG、AG基因型频率分别为0.71、0.29,而雌鱼中则为0.75和0.25;与体型、增重的相关性分析表明,此位点不同基因型只与雄鱼增重极显著相关(P0.01),GG型的雄鱼明显较AG型增重快。     

温度和盐度对吉富品系尼罗罗非鱼幼鱼鳃Na+-K+-ATPase活力的联合效应

试验采用中心组合设计(central composite face-centered design,CCF)和响应曲面法(response surface methodology,RSM)研究了温度(12—34℃)和盐度(0—26)两因素对体长为(4.36±0.105)cm,体重为(2.45±0.153)g的吉富品系尼罗罗非鱼(GIFT Nile tilapia,Oreochromis niloticus;简称吉富罗非鱼)幼鱼鳃Na+-K+-ATPase活力的联合效应。结果表明:(1)温度和盐度的一次效应和二次效应对Na+-K+-ATPase活力影响极显著(P<0.01),温度和盐度的互作效应不显著(P>0.05);(2)经响应曲面法分析,随着温度和盐度的增大,Na+-K+-ATPase活力呈先减小后增大的趋势;(3)建立了Na+-K+-ATPase活力与温度、盐度间关系的模型方程(R2=0.9829,Pred.R2=0.8550,P<0.01),并可用于预测吉富罗非鱼幼鱼鳃Na+-K+-ATPase的活力;(4)优化结果显示,温度为24.15℃,盐度为11.75时,Na+-K+-ATPase活力最小为0.62μmol无机磷.mg-1蛋白.h-1,满意度函数值高达0.961。Na+-K+-ATPase活力可以作为检测罗非鱼生长性能的指标,其活力较低时,一般反映了鱼体生存环境适宜,生长代谢旺盛,消耗于渗透调节的能量较少。     

遗传改良"新吉富" (NEW GIFT)尼罗罗非鱼RAPD-SCAR标记开发及其在品系鉴别中的应用

“新吉富”(NEW GIFT)尼罗罗非鱼是以1994年引进的 “吉富”(GIFT)品系尼罗罗非鱼为基础群体,经过14年9代系统选育后获得的新品种,该品种已被国家审定为良种,已在全国推广,迫切需要有效的分子遗传标记来鉴别该新品种并实施科学管理。该研究对良种群体开展了RAPD分析,并进一步将特异性的RAPD标记转化成了稳定的SCAR标记。 通过对“新吉富”群体的RAPD分析,找到了两个品种特异性的RAPD条带（S₃₀₄^{624 bp}和S₃₆^{568 bp}）。对品种特异性的RAPD条带进行了胶回收、克隆和序列测定。根据测序结果设计了两对位点特异性引物来扩增这两个品种特异性条带（简称SCAR标记Ⅰ和Ⅱ）,检测这两个SCAR标记在“新吉富”、“吉富”以及国内外7个养殖品系中的出现频率。SCAR标记Ⅰ（553 bp）在“新吉富”群体中的出现频率为85.7%,而在其基础群体（“吉富”）中的出现频率仅为16.7%;SCAR标记Ⅱ（558 bp）在“新吉富”群体中的出现频率达到91.4%,但在其它7个养殖品系中的出现频率仅在0%～70%之间。为验证这两个标记的可靠性,检测了这两个标记在一个埃及罗非鱼野生群体中的出现频率,发现SCAR标记Ⅰ和SCAR标记Ⅱ的出现频率分别为10%和70%,远低于在“新吉富”群体中的出现频率。这两个SCAR标记在“新吉富”良种群体中的高出现频率,预示它们可能与生长性能相关QTL位点间存在连锁关系,显示SCAR标记技术对选育世代间的纵向追溯、以及选育良种群体与其它养殖品系间的横向鉴别有较好应用前景。     

Case studies on the use of biotechnologies and on biosafety provisions in four African countries

This review is based on a study commissioned by the European Commission on the evaluation of scientific, technical and institutional challenges, priorities and bottlenecks for biotechnologies and regional harmonisation of biosafety in Africa. Biotechnology was considered within four domains: agricultural biotechnologies (‘Green’), industrial biotechnologies and biotechnologies for environmental remediation (‘White’), biotechnologies in aquaculture (‘Blue’) and biotechnologies for healthcare (‘Red’). An important consideration was the decline in partnerships between the EU and developing countries because of the original public antipathy to some green biotechnologies, particularly genetically modified organisms (GMOs) and food from GM crops in Europe. The study focus reported here was West Africa (Ghana, Senegal, Mali and Burkina Faso).The overall conclusion was that whereas high-quality research was proceeding in the countries visited, funding is not sustained and there is little evidence of practical application of biotechnology and benefit to farmers and the wider community. Research and development that was being carried out on genetically modified crop varieties was concentrating on improving food security and therefore unlikely to have significant impact on EU markets and consumers. However, there is much non-controversial green biotechnology such as molecular diagnostics for plant and animal disease and marker-assisted selection for breeding that has great potential application. Regarding white biotechnology, it is currently occupying only a very small industrial niche in West Africa, basically in the sole sector of the production of liquid biofuels (i.e., bio-ethanol) from indigenous and locally planted biomass (very often non-food crops). The presence of diffused small-scale fish production is the basis to develop and apply new (Blue) aquaculture technologies and, where the research conditions and the production sector can permit, to increase this type of production and the economy of this depressed areas. However, the problems bound to environmental protection must not be forgotten; priority should be given to monitor the risks of introduction of foreign species. Red biotechnologies potentially bring a vast domain of powerful tools and processes to achieve better human health, most notably improved diagnostics by molecular techniques, better targeting of pathogens and a better knowledge of their sensitivities to drugs to permit better treatment.Biosafety regulatory frameworks had been initiated in several countries, starting with primary biosafety law. However, disparate attitudes to the purpose of biosafety regulation (e.g., fostering informed decision-making versus ‘giving the green-light for a flood of GMOs’) currently prevent a needed consensus for sub-regional harmonisation. To date, most R&D funding has come from North America with some commercial interests from Asia, but African biotechnology workers expressed strong desire for (re-)engagement with interested parties from the European Union. Although in some of the visited countries there are very well qualified personnel in molecular biology and biosafety/regulation, the main message received is that human resources and capacity building in-house are still needed. This could be achieved through home-based courses and capacity-building including funds for post-degree research to motivate and retain trained staff.     

我国新引进吉富品系尼罗罗非鱼群体的遗传多样性分析

选取罗非鱼(Oreochromis spp.)第二代遗传连锁图谱中的26个微卫星位点,对淡水渔业研究中心引进的、由60个家系组成的吉富品系尼罗罗非鱼(O.niloticus)群体进行遗传结构分析。结果显示,26个微卫星位点在吉富罗非鱼群体中共检测到124个等位基因,各位点的等位基因数为3～7个,平均4.8个。片段长度104～322 bp,平均杂合度观测值为0.622 1,平均杂合度期望值为0.642 3,平均多态信息含量(PIC)为0.633 4。所检测的26个位点中,有25个位点属于高度多态位点(PIC0.5),占所检测位点的96.15%;1个位点属于中度多态位点。结果表明,该吉富罗非鱼群体多态信息含量丰富,遗传多样性水平较高。因而该群体仍然具有较大的选育潜力,可以作为选育的基础群体开展进一步的选育工作。     

吉富罗非鱼群体遗传多样性的AFLP分析

为了分析吉富罗非鱼的遗传多样性,为其育种提供理论依据,本实验利用5对引物组合(E-AGG/M-CTT, E-AGG/M-CTG, E-AAC/M-CAG, E-ACA/M-CTG, E-ACA/M-CAG)对广东省化州光辉养殖场有限公司新选育的吉富罗非鱼第16代群体(F16)进行遗传多样性的AFLP分析.27个个体共检出187个扩增位点,其中多态位点163个,平均每对引物扩增出32.6个位点,多态位点比例87.17%;平均Nei's基因多样性0.2886;平均Shannon's指数0.4339.结果说明实验群体存在较丰富的遗传多样性且保持有较高的遗传杂合度,具有进一步育种和开发的价值.     

低温应激对吉富罗非鱼血清生化指标及肝脏HSP70基因表达的影响

实验旨在探讨急性低温应激对吉富罗非鱼(GIFT,Oreochromis niloticus)血清生化、免疫指标以及肝脏HSP70 mRNA水平的影响。实验选取平均体重为(177±2.18)g左右的吉富罗非鱼作为实验对象,设定(25±1)℃对照组和低温(9±1)℃冷应激试验组,每组设定5个平行组,分别在0、2、6、12h随机采样,测定血清血糖(GLU)、胆固醇(CHOL) 、甘油三酯(TG)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、补体3 (C3)、补体4 (C4)、溶菌酶(LSZ)、皮质醇(COR)、三碘甲腺原氨酸(T3)、甲状腺素(T4)以及肝脏HSP70mRNA水平。结果表明:与对照组相比,试验组GLU水平在冷应激后6h,TG水平在冷应激后2、6h,CHOL水平在冷应激后6、12h均有显著升高(P<0.05),ALT水平在冷应激后2、12h均有显著升高(P<0.05);试验组AST、COR、T3水平在冷应激2、6、12h时出现显著升高(P<0.05),C3、C4、LSZ水平在冷应激后2、6、12h均出现显著下降(P<0.05);与对照组相比,试验组HSP70mRNA水平在冷应激后的12h出现显著升高(P<0.05)。因此,急性低温应激可以提高吉富罗非鱼肝脏应激蛋白HSP70mRNA水平,影响该鱼的非特异免疫力和相关生理指标。